A judge didn’t buy Johnson & Johnson to pay enough when he said the company should pay $465 million to deal with Oklahoma’s opioid crisis, the state said in an appeal filed Monday.
Lawyer General Mike Hunter’s workplace argues the award is just sufficient to spend for one year of the state’s abatement strategy. During last summertime’s trial, state specialists testified it would cost about $175 billion over 30 years to ease off the state’s opioid crisis. Lawyers for Johnson & Johnson have stated that figure is wildly pumped up.
The state also submitted an application with the court for repayment of litigation expenses.
Johnson & Johnson likewise is appealing the judge’s order, preserving the award ought to be lowered by $355 million to offset the pretrial settlements reached with other drugmakers. The company also preserves the judge misapplied the state’s public problem laws in reaching his choice.
Cleveland County District Judge Thad Balkman in August ruled Johnson & Johnson and its subsidiaries assisted fuel the opioid crisis with an aggressive and deceptive marketing project that overemphasized how effective the drugs were for dealing with persistent pain and downplayed the threat of addiction.
The judge at first ordered the company to pay $572 million, however later reduced that amount after acknowledging he made a miscalculation.